arrow
C

Christine Alewine

national institutes of health
H指数:21
被引数:1,833

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ASO Visual Abstract: Efficacy of Bidirectional Paclitaxel Plus Capecitabine or Nilotinib for Peritoneal Carcinomatosis: A Single-Institution Analysis of Two Phase II Clinical Trials

ASO视觉摘要:双向紫杉醇联合卡培他滨或尼罗替尼治疗腹膜癌病的疗效:一项单机构两项II期临床试验的分析

2026-02-070
PRE
Efficacy of Bidirectional Paclitaxel plus Capecitabine or Nilotinib for Peritoneal Carcinomatosis: A Single Institution Analysis of Two Phase II Clinical Trials
2026-01-160
OAAI
Controlled Self-Immolative Release of β-Lapachone via an Optimized para-Hydroxybenzyl Linker for Targeted Pancreatic Cancer Therapy

通过优化的对羟基苄基连接子实现β-拉帕酮的可控自消解释放,用于靶向胰腺癌治疗

2025-12-140
OAAI
Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers

托法替尼预防表达间皮素的晚期癌症患者针对LMB-100免疫毒素的抗药物抗体形成

2024-04-190
OAAI
Phase 1 study of the immunotoxin LMB-100 in patients with mesothelioma and other solid tumors expressing mesothelin

间皮瘤和其他实体瘤患者表达间皮素的免疫毒素LMB-100的1期研究

CANCER
IF5.1
2020-09-0140
OAAI